NDC 0603-2544-32 - Butalbital, Acetaminophen and Caffeine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0603-2544
- Requested NDC
- 0603-2544-32
- Package NDCs from labels
- 0603-2544-21, 0603-2544-28, 0603-2544-32
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2024-01-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Butalbital, Acetaminophen and Caffeine - Bryant Ranch Prepack | Bryant Ranch Prepack | 2024-01-10 | HUMAN PRESCRIPTION DRUG LABEL |
| Butalbital, Acetaminophen and Caffeine - Bryant Ranch Prepack | Bryant Ranch Prepack | 2023-11-30 | HUMAN PRESCRIPTION DRUG LABEL |
| Butalbital, Acetaminophen and Caffeine - Bryant Ranch Prepack | Bryant Ranch Prepack | 2023-06-02 | HUMAN PRESCRIPTION DRUG LABEL |
| Butalbital, Acetaminophen and Caffeine - American Health Packaging | American Health Packaging | 2022-10-19 | HUMAN PRESCRIPTION DRUG LABEL |
| Butalbital, Acetaminophen and Caffeine - Bryant Ranch Prepack | Bryant Ranch Prepack | 2021-12-21 | HUMAN PRESCRIPTION DRUG LABEL |
| Butalbital, Acetaminophen and Caffeine Tablets, USP 50 mg/325 mg/40 mg | Par Pharmaceutical, Inc. | 2019-10-25 | HUMAN PRESCRIPTION DRUG LABEL |
| Butalbital, Acetaminophen and Caffeine Tablets, USP 50 mg/325 mg/40 mg | PD-Rx Pharmaceuticals, Inc. | 2019-06-11 | HUMAN PRESCRIPTION DRUG LABEL |
| Butalbital, Acetaminophen and Caffeine - Carilion Materials Management | Carilion Materials Management | 2017-12-28 | HUMAN PRESCRIPTION DRUG LABEL |
| BUTALBITAL - Aphena Pharma Solutions - Tennessee, LLC | Aphena Pharma Solutions - Tennessee, LLC | 2014-06-02 | HUMAN PRESCRIPTION DRUG LABEL |
| BUTALBITAL, ACETAMINOPHEN AND CAFFEINE TABLETS, USP 50 mg/325 mg/40 mg | RedPharm Drug Inc. | Vintage Pharmaceuticals-Charlotte | Vintage Pharmaceuticals-Huntsville | 2011-08-15 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 0603-2544-21 | 2022-09-23 | Butalbital, Acetaminophen and Caffeine Tablets, USP 50 mg/325 mg/40 mg |
| 0603-2544-28 | 2022-09-23 | Butalbital, Acetaminophen and Caffeine Tablets, USP 50 mg/325 mg/40 mg |
| 0603-2544-21 | 2022-07-29 | Butalbital, Acetaminophen and Caffeine Tablets, USP 50 mg/325 mg/40 mg |
| 0603-2544-28 | 2022-07-29 | Butalbital, Acetaminophen and Caffeine Tablets, USP 50 mg/325 mg/40 mg |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0603-2544-02 | EA - Each | 0603-2544 | 6d3940e5-405c-4617-b515-3bc08e7821b4 | 1 | 2012-07-24 |
| 0603-2544-20 | EA - Each | 0603-2544 | 7c5a16d6-e74a-4c10-b412-e83cbcd553bb | 1 | 2012-07-24 |
| 0603-2544-21 | EA - Each | 0603-2544 | f19c6430-f6dd-454f-8922-08d791f0c2d9 | 1 | 2012-07-24 |
| 0603-2544-28 | EA - Each | 0603-2544 | 104552f5-81aa-4314-bbff-8fc084c1ff51 | 1 | 2012-07-24 |
| 0603-2544-32 | EA - Each | 0603-2544 | 22eab70a-0a83-42ee-ad07-d498e25639ab | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NyQuil Severe plus Vicks VapoCool Cold and Flu | ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE, DOXYLAMINE SUCCINATE, AND DEXTROMETHORPHAN HYDROBROMIDE | The Procter & Gamble Manufacturing Company | 724d0889-5ba5-3125-e053-2a91aa0a92c1 | 2026-11-04 | Warnings | 362O9ITL9D |
| Vicks DayQuil HIGH BLOOD PRESSURE COLD and FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HBR | The Procter & Gamble Manufacturing Company | ff0bffee-9a36-8246-e053-6294a90a86c7 | 2026-11-04 | Warnings | 362O9ITL9D |
| Desresfriol-DX Softgels | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE | OPMX LLC. | ff5e0e0f-bfd2-b02b-e053-6394a90afe8a | 2026-11-04 | Warnings | 362O9ITL9D |
| Migrafein FORTE | ACETAMINOPHEN, CAFFEINE | OPMX LLC | 028875c9-4129-ce2c-e063-6294a90a26cc | 2026-11-04 | Warnings | 3G6A5W338E 362O9ITL9D |
| Neo-Lubrina Fuerte | ACETAMINOPHEN, CAFFEINE | OPMX LLC | 0288a327-fd4b-1991-e063-6294a90ace50 | 2026-11-04 | Warnings | 3G6A5W338E 362O9ITL9D |
| CAFIZETAMOL FORTE | ACETAMINOPHEN, CAFFEINE | OPMX LLC | 028771d3-a514-f7a5-e063-6394a90ac4f3 | 2026-11-04 | Warnings | 3G6A5W338E 362O9ITL9D |
| Buscapina | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | OPMX LLC | 048c4b03-1cf4-b724-e063-6294a90a1cad | 2026-11-04 | Warnings | 3G6A5W338E 362O9ITL9D |
| Tenalif Children | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | OPMX LLC | 05cd9513-1a42-e990-e063-6294a90a57df | 2026-11-04 | Warnings | 362O9ITL9D |
| Rompe Tos X Children | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | OPMX LLC | 05cc932d-b412-0710-e063-6394a90a87f6 | 2026-11-04 | Warnings | 362O9ITL9D |
| Rompe Tos X Adults | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | OPMX LLC | 05abb2db-d22e-90b5-e063-6294a90ace3f | 2026-11-04 | Warnings | 362O9ITL9D |
| Tenalif Multi Symptom Relief | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | OPMX LLC | 05cd94e7-1808-3bb3-e063-6294a90a4140 | 2026-11-04 | Warnings | 362O9ITL9D |
| tabcin NIGHT | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | OPMX LLC | 0b3ed2bb-88ed-699e-e063-6394a90ac023 | 2026-11-04 | Warnings | 362O9ITL9D |
| Mejoral | ACETAMINOPHEN, CAFFEINE | OPMX LLC | 0bccf571-fcb9-2dd5-e063-6294a90a5f16 | 2026-11-04 | Warnings | 3G6A5W338E 362O9ITL9D |
| RESFRIOL D | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL | OPMX LLC | 0e9c96b9-41ac-0faf-e063-6294a90a8ab5 | 2026-11-04 | Warnings | 362O9ITL9D |
| Ampigrin Ultra Forte Night | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | OPMX LLC | e11e71c3-fe7c-77c7-e053-2995a90a34b2 | 2026-11-04 | Warnings | 362O9ITL9D |
| Nitecin | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | OPMX LLC | dfb56532-6f72-1e4d-e053-2a95a90a1c05 | 2026-11-04 | Warnings | 362O9ITL9D |
| Pentrexcilina Night Time | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | OPMX LLC | e11e5c17-28f2-7186-e053-2995a90a51f6 | 2026-11-04 | Warnings | 362O9ITL9D |
| Viro Flu PM Relief | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | OPMX LLC | e1553da8-3a89-e258-e053-2a95a90a4725 | 2026-11-04 | Warnings | 362O9ITL9D |
| Activcin | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE | OPMX LLC. | e06a4d72-cc8d-fd9d-e053-2995a90a7a76 | 2026-11-04 | Warnings | 362O9ITL9D |
| Dolex Forte | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Pharmadel LLC | 3c2d90fc-130d-476c-e063-6294a90a8c15 | 2026-11-03 | Warnings | 3G6A5W338E 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.